Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,378,471 papers from all fields of science
Search
Sign In
Create Free Account
Cobimetinib 20 MG Oral Tablet [Cotellic]
Known as:
COBIMETINIB FUMARATE 20 mg ORAL TABLET, FILM COATED [Cotellic]
, Cotellic 20 MG (as cobimetinib fumarate 22 MG) Oral Tablet
, Cotellic 20 MG Oral Tablet
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Cobimetinib
Cotellic
Croscarmellose Sodium
Lactose Monohydrate
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Cobimetinib in malignant melanoma: how to MEK an impact on long-term survival.
A. Indini
,
C. Tondini
,
M. Mandalà
Future Oncology
2019
Corpus ID: 58591783
Approximately 50% of cutaneous melanomas harbor activating mutations of the BRAF-oncogene, making BRAF inhibitors (BRAFi) the…
Expand
2018
2018
Roche provides update on Phase III study of Tecentriq (atezolizumab) and Cotellic (combimetinib) in people with heavily pre-treated locally advanced or metastatic colorectal cancer
2018
Corpus ID: 52253483
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMblaze370 study evaluating the combination of Tecentriq…
Expand
2017
2017
Duale Signalweginhibition: Hohe Langzeitwirkung, gute Verträglichkeit
C. Cramer
Der Deutsche Dermatologe
2017
Corpus ID: 189294385
2017
2017
Vielversprechender neuer Antikörper bei mittelschwerer bis schwerer Psoriasis
Christine Leist
Der Deutsche Dermatologe
2017
Corpus ID: 80550602
Patienten mit einem fortgeschrittenen, BRAF-V600-mutierten Melanom protieren von einer Kombinationstherapie mit dem BRAF…
Expand
Review
2016
Review
2016
Cobimetinib Plus Vemurafenib: A Review in BRAFV600 Mutation-Positive Unresectable or Metastatic Melanoma
G. Keating
Drugs
2016
Corpus ID: 24973007
The MEK inhibitor cobimetinib (Cotellic®) is indicated for the treatment of patients with BRAFV600 mutation-positive unresectable…
Expand
2016
2016
Cometinib (Cotellic°) and metastic melanoma.
Prescrire international
2016
Corpus ID: 73453762
Review
2014
Review
2014
Evaluación positiva de medicamentos: septiembre/octubre/noviembre 2013
A. Tabakov
,
A. G. Luque
,
M. C. Mariscal
,
P. S. López
2014
Corpus ID: 72324686
espanolSe resenan los medicamentos evaluados y con dictamen positivo por comision de expertos de la Agencia Espanola de…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE